{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T14:52:10Z","timestamp":1778770330461,"version":"3.51.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,12,23]],"date-time":"2020-12-23T00:00:00Z","timestamp":1608681600000},"content-version":"vor","delay-in-days":22,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Rhinoviruses and influenza viruses cause millions of acute respiratory infections annually. Symptoms of mild acute respiratory infections are commonly treated with over-the-counter products like ambroxol, bromhexine, and N-acetyl cysteine, as well as of thyme and pelargonium extracts today. Because the direct antiviral activity of these over-the-counter products has not been studied in a systematic way, the current study aimed to compare their inhibitory effect against rhinovirus and influenza virus replication in an in vitro setting.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The cytotoxicity of ambroxol, bromhexine, and N-acetyl cysteine, as well as of thyme and pelargonium extracts was analyzed in Madin Darby canine kidney (MDCK) and HeLa Ohio cells. The antiviral effect of these over-the-counter products was compared by analyzing the dose-dependent inhibition (i) of rhinovirus A2- and B14-induced cytopathic effect in HeLa Ohio cells and (ii) of influenza virus A\/Hong Kong\/68 (subtype H3N2)- and A\/Jena\/8178\/09 (subtype H1N1, pandemic)-induced cytopathic effect in MDCK cells at non-cytotoxic concentrations. To get insights into the mechanism of action of pelargonium extract against influenza virus, we performed time-of-addition assays as well as hemagglutination and neuraminidase inhibition assays.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>N-acetyl cysteine, thyme and pelargonium extract showed no or only marginal cytotoxicity in MDCK and HeLa Ohio cells in the tested concentration range. The 50% cytotoxic concentration of ambroxol and bromhexine was 51.85 and 61.24\u2009\u03bcM, respectively. No anti-rhinoviral activity was detected at non-cytotoxic concentrations in this in vitro study setting. Ambroxol, bromhexine, and N-acetyl cysteine inhibited the influenza virus-induced cytopathic effect in MDCK cells no or less than 50%. In contrast, a dose-dependent anti-influenza virus activity of thyme and pelargonium extracts was demonstrated. The time-of addition assays revealed an inhibition of early and late steps of influenza virus replication by pelargonium extract whereas zanamivir acted on late steps only. The proven block of viral neuraminidase activity might explain the inhibition of influenza virus replication when added after viral adsorption.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The study results indicate a distinct inhibition of influenza A virus replication by thyme and pelargonium extract which might contribute to the beneficial effects of these plant extracts on acute respiratory infections symptoms.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12906-020-03173-2","type":"journal-article","created":{"date-parts":[[2020,12,23]],"date-time":"2020-12-23T15:04:44Z","timestamp":1608735884000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Comparative in vitro analysis of inhibition of rhinovirus and influenza virus replication by mucoactive secretolytic agents and plant extracts"],"prefix":"10.1186","volume":"20","author":[{"given":"Christin","family":"Walther","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin","family":"D\u00f6ring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michaela","family":"Schmidtke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,12,23]]},"reference":[{"key":"3173_CR1","volume-title":"Home\/Newsroom\/Fact sheets\/Detail: World Health Organisation","author":"The top 10 causes of death","year":"2020","unstructured":"The top 10 causes of death. Home\/Newsroom\/Fact sheets\/Detail: World Health Organisation; 2020 [updated 24 May 2018. Available from: http:\/\/fmrglobalhealth.com\/frame\/top10.html]."},{"issue":"12","key":"3173_CR2","doi-asserted-by":"publisher","first-page":"981","DOI":"10.7326\/0003-4819-133-12-200012190-00014","volume":"133","author":"R Gonzales","year":"2000","unstructured":"Gonzales R, Sande MA. Uncomplicated acute bronchitis. Ann Intern Med. 2000;133(12):981\u201391. https:\/\/doi.org\/10.7326\/0003-4819-133-12-200012190-00014.","journal-title":"Ann Intern Med"},{"issue":"5","key":"3173_CR3","doi-asserted-by":"publisher","first-page":"e1008536","DOI":"10.1371\/journal.ppat.1008536","volume":"16","author":"D Tang","year":"2020","unstructured":"Tang D, Comish P, Kang R. The hallmarks of covid-19 disease. PLoS Pathog. 2020;16(5):e1008536. https:\/\/doi.org\/10.1371\/journal.ppat.1008536.","journal-title":"PLoS Pathog"},{"issue":"9351","key":"3173_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0140-6736(03)12162-9","volume":"361","author":"T Heikkinen","year":"2003","unstructured":"Heikkinen T, Jarvinen A. The common cold. Lancet. 2003;361(9351):51\u20139. https:\/\/doi.org\/10.1016\/S0140-6736(03)12162-9.","journal-title":"Lancet."},{"issue":"1","key":"3173_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jinf.2016.09.003","volume":"74","author":"S Taylor","year":"2017","unstructured":"Taylor S, Lopez P, Weckx L, Borja-Tabora C, Ulloa-Gutierrez R, Lazcano-Ponce E, Kerdpanich A, Angel Rodriguez Weber M, Mascarenas de Los Santos A, Tinoco JC, Safadi MA, Lim FS, Hernandez-de Mezerville M, Faingezicht I, Cruz-Valdez A, Feng Y, Li P, Durviaux S, Haars G, Roy-Ghanta S, Vaughn DW, Nolan T. Respiratory viruses and influenza-like illness: Epidemiology and outcomes in children aged 6 months to 10 years in a multi-country population sample. J Inf Secur. 2017;74(1):29\u201341. https:\/\/doi.org\/10.1016\/j.jinf.2016.09.003.","journal-title":"J Inf Secur"},{"key":"3173_CR6","volume-title":"Home\/Newsroom\/Fact sheets\/Detail: World Health Organisation","author":"Influenza (seasonal)","year":"2020","unstructured":"Influenza (seasonal). Home\/Newsroom\/Fact sheets\/Detail: World Health Organisation; 2020 [updated 6 November 2018. Available from: https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/influenza-(seasonal)."},{"key":"3173_CR7","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.ejmech.2019.06.008","volume":"178","author":"A Egorova","year":"2019","unstructured":"Egorova A, Ekins S, Schmidtke M, Makarov V. Back to the future: advances in development of broad-spectrum capsid-binding inhibitors of enteroviruses. Eur J Med Chem. 2019;178:606\u201322. https:\/\/doi.org\/10.1016\/j.ejmech.2019.06.008.","journal-title":"Eur J Med Chem"},{"issue":"1","key":"3173_CR8","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/med.20176","volume":"31","author":"JM Rollinger","year":"2011","unstructured":"Rollinger JM, Schmidtke M. The human rhinovirus: human-pathological impact, mechanisms of antirhinoviral agents, and strategies for their discovery. Med Res Rev. 2011;31(1):42\u201392. https:\/\/doi.org\/10.1002\/med.20176.","journal-title":"Med Res Rev"},{"issue":"8","key":"3173_CR9","doi-asserted-by":"publisher","first-page":"e1008762","DOI":"10.1371\/journal.ppat.1008762","volume":"16","author":"A Mittal","year":"2020","unstructured":"Mittal A, Manjunath K, Ranjan RK, Kaushik S, Kumar S, Verma V. Covid-19 pandemic: insights into structure, function, and hace2 receptor recognition by sars-cov-2. PLoS Pathog. 2020;16(8):e1008762. https:\/\/doi.org\/10.1371\/journal.ppat.1008762.","journal-title":"PLoS Pathog"},{"key":"3173_CR10","doi-asserted-by":"publisher","unstructured":"Cataldi JR, O'Leary ST, Lindley MC, Hurley LP, Allison MA, Brtnikova M, Beaty BL, Crane LA, Kempe A. Survey of adult influenza vaccination practices and perspectives among us primary care providers (2016-2017 influenza season). J Gen Intern Med. 2019. https:\/\/doi.org\/10.1007\/s11606-019-05164-7.","DOI":"10.1007\/s11606-019-05164-7"},{"issue":"5","key":"3173_CR11","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s15010-016-0920-0","volume":"44","author":"S Hagel","year":"2016","unstructured":"Hagel S, Ludewig K, Moeser A, Baier M, Loffler B, Schleenvoigt B, Forstner C, Pletz MW. Characteristics and management of patients with influenza in a german hospital during the 2014\/2015 influenza season. Infection. 2016;44(5):667\u201372. https:\/\/doi.org\/10.1007\/s15010-016-0920-0.","journal-title":"Infection."},{"issue":"4","key":"3173_CR12","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.vaccine.2017.12.019","volume":"36","author":"P Jorgensen","year":"2018","unstructured":"Jorgensen P, Mereckiene J, Cotter S, Johansen K, Tsolova S, Brown C. How close are countries of the who european region to achieving the goal of vaccinating 75% of key risk groups against influenza? Results from national surveys on seasonal influenza vaccination programmes, 2008\/2009 to 2014\/2015. Vaccine. 2018;36(4):442\u201352. https:\/\/doi.org\/10.1016\/j.vaccine.2017.12.019.","journal-title":"Vaccine."},{"issue":"48","key":"3173_CR13","doi-asserted-by":"publisher","first-page":"7262","DOI":"10.1016\/j.vaccine.2018.10.045","volume":"36","author":"Q Wang","year":"2018","unstructured":"Wang Q, Yue N, Zheng M, Wang D, Duan C, Yu X, Zhang X, Bao C, Jin H. Influenza vaccination coverage of population and the factors influencing influenza vaccination in mainland China: a meta-analysis. Vaccine. 2018;36(48):7262\u20139. https:\/\/doi.org\/10.1016\/j.vaccine.2018.10.045.","journal-title":"Vaccine."},{"key":"3173_CR14","doi-asserted-by":"publisher","first-page":"104545","DOI":"10.1016\/j.antiviral.2019.104545","volume":"169","author":"EJ Mifsud","year":"2019","unstructured":"Mifsud EJ, Hayden FG, Hurt AC. Antivirals targeting the polymerase complex of influenza viruses. Antivir Res. 2019;169:104545. https:\/\/doi.org\/10.1016\/j.antiviral.2019.104545.","journal-title":"Antivir Res"},{"key":"3173_CR15","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.coph.2016.08.003","volume":"30","author":"L Naesens","year":"2016","unstructured":"Naesens L, Stevaert A, Vanderlinden E. Antiviral therapies on the horizon for influenza. Curr Opin Pharmacol. 2016;30:106\u201315. https:\/\/doi.org\/10.1016\/j.coph.2016.08.003.","journal-title":"Curr Opin Pharmacol"},{"issue":"8","key":"3173_CR16","doi-asserted-by":"publisher","first-page":"e1006450","DOI":"10.1371\/journal.ppat.1006450","volume":"13","author":"KEE Johnson","year":"2017","unstructured":"Johnson KEE, Song T, Greenbaum B, Ghedin E. Getting the flu: 5 key facts about influenza virus evolution. PLoS Pathog. 2017;13(8):e1006450. https:\/\/doi.org\/10.1371\/journal.ppat.1006450.","journal-title":"PLoS Pathog"},{"key":"3173_CR17","doi-asserted-by":"publisher","unstructured":"To J, Torres J. Viroporins in the influenza virus. Cells. 2019;8(7). https:\/\/doi.org\/10.3390\/cells8070654.","DOI":"10.3390\/cells8070654"},{"issue":"619","key":"3173_CR18","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.3399\/bjgp14X677130","volume":"64","author":"M Hamoen","year":"2014","unstructured":"Hamoen M, Broekhuizen BD, Little P, Melbye H, Coenen S, Goossens H, Butler CC, Francis NA, Verheij TJ. Group Gcs. Medication use in european primary care patients with lower respiratory tract infection: an observational study. Br J Gen Pract. 2014;64(619):e81\u201391. https:\/\/doi.org\/10.3399\/bjgp14X677130.","journal-title":"Br J Gen Pract"},{"key":"3173_CR19","doi-asserted-by":"publisher","first-page":"117955061882193","DOI":"10.1177\/1179550618821930","volume":"12","author":"F Scaglione","year":"2019","unstructured":"Scaglione F, Petrini O. Mucoactive agents in the therapy of upper respiratory airways infections: fair to describe them just as mucoactive? Clin Med Insights Ear Nose Throat. 2019;12:1179550618821930. https:\/\/doi.org\/10.1177\/1179550618821930.","journal-title":"Clin Med Insights Ear Nose Throat"},{"issue":"11","key":"3173_CR20","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1517\/17460441.2011.629646","volume":"6","author":"D Paleari","year":"2011","unstructured":"Paleari D, Rossi GA, Nicolini G, Olivieri D. Ambroxol: a multifaceted molecule with additional therapeutic potentials in respiratory disorders of childhood. Expert Opin Drug Discovery. 2011;6(11):1203\u201314. https:\/\/doi.org\/10.1517\/17460441.2011.629646.","journal-title":"Expert Opin Drug Discovery"},{"issue":"5","key":"3173_CR21","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.phymed.2007.11.023","volume":"15","author":"TB Agbabiaka","year":"2008","unstructured":"Agbabiaka TB, Guo R, Ernst E. Pelargonium sidoides for acute bronchitis: a systematic review and meta-analysis. Phytomedicine. 2008;15(5):378\u201385. https:\/\/doi.org\/10.1016\/j.phymed.2007.11.023.","journal-title":"Phytomedicine."},{"key":"3173_CR22","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2147\/IJGM.S154198","volume":"11","author":"D Careddu","year":"2018","unstructured":"Careddu D, Pettenazzo A. Pelargonium sidoides extract eps 7630: a review of its clinical efficacy and safety for treating acute respiratory tract infections in children. Int J Gen Med. 2018;11:91\u20138. https:\/\/doi.org\/10.2147\/IJGM.S154198.","journal-title":"Int J Gen Med"},{"issue":"9","key":"3173_CR23","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1002\/ptr.6109","volume":"32","author":"B Salehi","year":"2018","unstructured":"Salehi B, Mishra AP, Shukla I, Sharifi-Rad M, Contreras MDM, Segura-Carretero A, Fathi H, Nasrabadi NN, Kobarfard F, Sharifi-Rad J. Thymol, thyme, and other plant sources: health and potential uses. Phytother Res. 2018;32(9):1688\u2013706. https:\/\/doi.org\/10.1002\/ptr.6109.","journal-title":"Phytother Res"},{"issue":"4","key":"3173_CR24","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1007\/s12272-013-0210-7","volume":"37","author":"M Yamaya","year":"2014","unstructured":"Yamaya M, Nishimura H, Nadine LK, Ota C, Kubo H, Nagatomi R. Ambroxol inhibits rhinovirus infection in primary cultures of human tracheal epithelial cells. Arch Pharm Res. 2014;37(4):520\u20139. https:\/\/doi.org\/10.1007\/s12272-013-0210-7.","journal-title":"Arch Pharm Res"},{"issue":"5","key":"3173_CR25","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1183\/09031936.02.00253302","volume":"19","author":"B Yang","year":"2002","unstructured":"Yang B, Yao DF, Ohuchi M, Ide M, Yano M, Okumura Y, Kido H. Ambroxol suppresses influenza-virus proliferation in the mouse airway by increasing antiviral factor levels. Eur Respir J. 2002;19(5):952\u20138.","journal-title":"Eur Respir J"},{"issue":"2","key":"3173_CR26","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1177\/039463200702000215","volume":"20","author":"A Garozzo","year":"2007","unstructured":"Garozzo A, Tempera G, Ungheri D, Timpanaro R, Castro A. N-acetylcysteine synergizes with oseltamivir in protecting mice from lethal influenza infection. Int J Immunopathol Pharmacol. 2007;20(2):349\u201354. https:\/\/doi.org\/10.1177\/039463200702000215.","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"3","key":"3173_CR27","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.bcp.2009.08.025","volume":"79","author":"J Geiler","year":"2010","unstructured":"Geiler J, Michaelis M, Naczk P, Leutz A, Langer K, Doerr HW, Cinatl J Jr. N-acetyl-l-cysteine (nac) inhibits virus replication and expression of pro-inflammatory molecules in a549 cells infected with highly pathogenic h5n1 influenza a virus. Biochem Pharmacol. 2010;79(3):413\u201320. https:\/\/doi.org\/10.1016\/j.bcp.2009.08.025.","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"3173_CR28","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.bcp.2011.05.014","volume":"82","author":"M Mata","year":"2011","unstructured":"Mata M, Morcillo E, Gimeno C, Cortijo J. N-acetyl-l-cysteine (nac) inhibit mucin synthesis and pro-inflammatory mediators in alveolar type ii epithelial cells infected with influenza virus a and b and with respiratory syncytial virus (rsv). Biochem Pharmacol. 2011;82(5):548\u201355. https:\/\/doi.org\/10.1016\/j.bcp.2011.05.014.","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"3173_CR29","first-page":"123","volume":"13","author":"D Ungheri","year":"2000","unstructured":"Ungheri D, Pisani C, Sanson G, Bertani A, Schioppacassi G, Delgado R, Sironi M, Ghezzi P. Protective effect of n-acetylcysteine in a model of influenza infection in mice. Int J Immunopathol Pharmacol. 2000;13(3):123\u20138.","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"5","key":"3173_CR30","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.phymed.2010.09.008","volume":"18","author":"M Michaelis","year":"2011","unstructured":"Michaelis M, Doerr HW, Cinatl J Jr. Investigation of the influence of eps(r) 7630, a herbal drug preparation from pelargonium sidoides, on replication of a broad panel of respiratory viruses. Phytomedicine. 2011;18(5):384\u20136. https:\/\/doi.org\/10.1016\/j.phymed.2010.09.008.","journal-title":"Phytomedicine."},{"issue":"2","key":"3173_CR31","doi-asserted-by":"publisher","first-page":"e0210702","DOI":"10.1371\/journal.pone.0210702","volume":"14","author":"M Roth","year":"2019","unstructured":"Roth M, Fang L, Stolz D, Tamm M. Pelargonium sidoides radix extract eps 7630 reduces rhinovirus infection through modulation of viral binding proteins on human bronchial epithelial cells. PLoS One. 2019;14(2):e0210702. https:\/\/doi.org\/10.1371\/journal.pone.0210702.","journal-title":"PLoS One"},{"issue":"2","key":"3173_CR32","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.antiviral.2012.03.006","volume":"94","author":"LL Theisen","year":"2012","unstructured":"Theisen LL, Muller CP. Eps(r) 7630 (umckaloabo(r)), an extract from pelargonium sidoides roots, exerts anti-influenza virus activity in vitro and in vivo. Antivir Res. 2012;94(2):147\u201356. https:\/\/doi.org\/10.1016\/j.antiviral.2012.03.006.","journal-title":"Antivir Res"},{"issue":"7","key":"3173_CR33","doi-asserted-by":"publisher","first-page":"3663","DOI":"10.1128\/JVI.78.7.3663-3674.2004","volume":"78","author":"RM Ledford","year":"2004","unstructured":"Ledford RM, Patel NR, Demenczuk TM, Watanyar A, Herbertz T, Collett MS, Pevear DC. Vp1 sequencing of all human rhinovirus serotypes: insights into genus phylogeny and susceptibility to antiviral capsid-binding compounds. J Virol. 2004;78(7):3663\u201374.","journal-title":"J Virol"},{"issue":"10","key":"3173_CR34","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1002\/cmdc.201500304","volume":"10","author":"VA Makarov","year":"2015","unstructured":"Makarov VA, Braun H, Richter M, Riabova OB, Kirchmair J, Kazakova ES, Seidel N, Wutzler P, Schmidtke M. Pyrazolopyrimidines: potent inhibitors targeting the capsid of rhino- and enteroviruses. ChemMedChem. 2015;10(10):1629\u201334. https:\/\/doi.org\/10.1002\/cmdc.201500304.","journal-title":"ChemMedChem."},{"issue":"1","key":"3173_CR35","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1039\/c1np00053e","volume":"29","author":"U Grienke","year":"2012","unstructured":"Grienke U, Schmidtke M, von Grafenstein S, Kirchmair J, Liedl KR, Rollinger JM. Influenza neuraminidase: a druggable target for natural products. Nat Prod Rep. 2012;29(1):11\u201336. https:\/\/doi.org\/10.1039\/c1np00053e.","journal-title":"Nat Prod Rep"},{"issue":"9","key":"3173_CR36","doi-asserted-by":"publisher","first-page":"3208","DOI":"10.1002\/jps.24508","volume":"104","author":"D Schade","year":"2015","unstructured":"Schade D, Kotthaus J, Riebling L, Kotthaus J, Muller-Fielitz H, Raasch W, Hoffmann A, Schmidtke M, Clement B. Zanamivir amidoxime- and n-hydroxyguanidine-based prodrug approaches to tackle poor oral bioavailability. J Pharm Sci. 2015;104(9):3208\u201319. https:\/\/doi.org\/10.1002\/jps.24508.","journal-title":"J Pharm Sci"},{"key":"3173_CR37","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3389\/fmicb.2016.00357","volume":"7","author":"E Walther","year":"2016","unstructured":"Walther E, Xu Z, Richter M, Kirchmair J, Grienke U, Rollinger JM, Krumbholz A, Saluz HP, Pfister W, Sauerbrei A, Schmidtke M. Dual acting neuraminidase inhibitors open new opportunities to disrupt the lethal synergism between streptococcus pneumoniae and influenza virus. Front Microbiol. 2016;7:357. https:\/\/doi.org\/10.3389\/fmicb.2016.00357.","journal-title":"Front Microbiol"},{"issue":"9\u201310","key":"3173_CR38","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1055\/a-0590-5153","volume":"84","author":"U Grienke","year":"2018","unstructured":"Grienke U, Mair CE, Kirchmair J, Schmidtke M, Rollinger JM. Discovery of bioactive natural products for the treatment of acute respiratory infections - an integrated approach. Planta Med. 2018;84(9\u201310):684\u201395. https:\/\/doi.org\/10.1055\/a-0590-5153.","journal-title":"Planta Med"},{"issue":"1\u20132","key":"3173_CR39","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0166-0934(01)00305-6","volume":"95","author":"M Schmidtke","year":"2001","unstructured":"Schmidtke M, Schnittler U, Jahn B, Dahse H, Stelzner A. A rapid assay for evaluation of antiviral activity against coxsackie virus b3, influenza virus a, and herpes simplex virus type 1. J Virol Methods. 2001;95(1\u20132):133\u201343.","journal-title":"J Virol Methods"},{"issue":"4","key":"3173_CR40","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/0166-0934(88)90134-6","volume":"20","author":"R Pauwels","year":"1988","unstructured":"Pauwels R, Balzarini J, Baba M, Snoeck R, Schols D, Herdewijn P, Desmyter J, De Clercq E. Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-hiv compounds. J Virol Methods. 1988;20(4):309\u201321.","journal-title":"J Virol Methods"},{"issue":"38","key":"3173_CR41","doi-asserted-by":"publisher","first-page":"19109","DOI":"10.1073\/pnas.1904732116","volume":"116","author":"J Wald","year":"2019","unstructured":"Wald J, Pasin M, Richter M, Walther C, Mathai N, Kirchmair J, Makarov VA, Goessweiner-Mohr N, Marlovits TC, Zanella I, Real-Hohn A, Verdaguer N, Blaas D, Schmidtke M. Cryo-em structure of pleconaril-resistant rhinovirus-b5 complexed to the antiviral obr-5-340 reveals unexpected binding site. Proc Natl Acad Sci U S A. 2019;116(38):19109\u201315. https:\/\/doi.org\/10.1073\/pnas.1904732116.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3173_CR42","doi-asserted-by":"publisher","unstructured":"Kaufmann L, Syedbasha M, Vogt D, Hollenstein Y, Hartmann J, Linnik JE, Egli A. An optimized hemagglutination inhibition (hi) assay to quantify influenza-specific antibody titers. J Vis Exp. 2017;130. https:\/\/doi.org\/10.3791\/55833.","DOI":"10.3791\/55833"},{"issue":"2","key":"3173_CR43","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2217\/Fvl.14.97","volume":"10","author":"M Richter","year":"2015","unstructured":"Richter M, Schumann L, Walther E, Hoffmann A, Braun H, Grienke U, Rollinger JM, von Grafenstein S, Liedl KR, Kirchmair J, Wutzler P, Sauerbrei A, Schmidtke M. Complementary assays helping to overcome challenges for identifying neuraminidase inhibitors. Futur Virol. 2015;10(2):77\u201388. https:\/\/doi.org\/10.2217\/Fvl.14.97.","journal-title":"Futur Virol"},{"issue":"1\u20132","key":"3173_CR44","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jchromb.2007.03.015","volume":"853","author":"F Su","year":"2007","unstructured":"Su F, Wang F, Gao W, Li H. Determination of ambroxol in human plasma by high performance liquid chromatography-electrospray ionization mass spectrometry (hplc-ms\/esi). J Chromatogr B Anal Technol Biomed Life Sci. 2007;853(1\u20132):364\u20138. https:\/\/doi.org\/10.1016\/j.jchromb.2007.03.015.","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci"},{"issue":"2","key":"3173_CR45","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/bdd.2510110205","volume":"11","author":"L Borgstrom","year":"1990","unstructured":"Borgstrom L, Kagedal B. Dose dependent pharmacokinetics of n-acetylcysteine after oral dosing to man. Biopharm Drug Dispos. 1990;11(2):131\u20136.","journal-title":"Biopharm Drug Dispos"},{"issue":"1","key":"3173_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.intimp.2014.06.013","volume":"22","author":"RH Zhang","year":"2014","unstructured":"Zhang RH, Li CH, Wang CL, Xu MJ, Xu T, Wei D, Liu BJ, Wang GH, Tian SF. N-acetyl-l-cystine (nac) protects against h9n2 swine influenza virus-induced acute lung injury. Int Immunopharmacol. 2014;22(1):1\u20138. https:\/\/doi.org\/10.1016\/j.intimp.2014.06.013.","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"3173_CR47","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1093\/ecam\/nem156","volume":"6","author":"M Rajbhandari","year":"2009","unstructured":"Rajbhandari M, Mentel R, Jha PK, Chaudhary RP, Bhattarai S, Gewali MB, Karmacharya N, Hipper M, Lindequist U. Antiviral activity of some plants used in nepalese traditional medicine. Evid Based Complement Alternat Med. 2009;6(4):517\u201322. https:\/\/doi.org\/10.1093\/ecam\/nem156.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"8","key":"3173_CR48","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1002\/ptr.6084","volume":"32","author":"MM Toujani","year":"2018","unstructured":"Toujani MM, Ritta M, Civra A, Genovese S, Epifano F, Ghram A, Lembo D, Donalisio M. Inhibition of hsv-2 infection by pure compounds from thymus capitatus extract in vitro. Phytother Res. 2018;32(8):1555\u201363. https:\/\/doi.org\/10.1002\/ptr.6084.","journal-title":"Phytother Res"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-020-03173-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12906-020-03173-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-020-03173-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,23]],"date-time":"2020-12-23T15:06:41Z","timestamp":1608736001000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-020-03173-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3173"],"URL":"https:\/\/doi.org\/10.1186\/s12906-020-03173-2","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"28 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"380"}}